(Aditya Shaw, Intern Journalist): The corona virus is another good news for the world awaiting vaccine. The Oxford AstraZeneca Covid vaccine was more than 70% effective in the Phase 3 trial. According to the interim analysis released on Monday, the efficacy of vaccine was 70.4% when the two types of doses were put together. According to researchers, the vaccine was found to be up to 90% effective when isolated. The vaccine was more effective when the first dose was light and the second normal. That is, early indications suggest that vaccine may reduce virus transmission. Vaccine safe has also been found and no volunteer was required to be admitted to the hospital.
According to Professor Andrew Pollard, director of the Oxford Vaccine Group and the Chief Investigator of the trial, “These results show that an effective vaccine can save many lives.” He said that in one of the four patterns of dose, the vaccine was effective up to 90% and if we adopt the same pattern, many people can be given the vaccine. It was found in the trial that if the first dose of vaccine is given in half and the second dose is complete then it affects up to 90%.
Oxford and AstraZeneca will now put this interim analysis of vaccine in front of drug regulators in the UK. If the vaccine receives emergency approval, the vaccine may be available from December. The Indian company Serum Institute of India will also be eyeing emergency approvals in the UK. He has signed 100 million doses of vaccine with AstraZeneca. If emergency approval is found in the UK, then the company can apply for emergency approval based on the same vaccine data in India as well. If this happens, then the vaccine can be available in India by the name of ‘Covishield’ till January.
A database of over 24,000 volunteers in the United Kingdom, Brazil, and South Africa was used for the interim analysis of this vaccine. This vaccine can be easily distributed under the current health care system as it has to be stored at a temperature of 2 to 8 degrees Celsius. In a statement, Oxford said that more than 10 countries continue to produce vaccines.
About Post Author
